Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MMEDF - MindMed: Severely Undervalued With Massive Upside Yet To Come

MMEDF - MindMed: Severely Undervalued With Massive Upside Yet To Come

Mind Medicine
  • MindMed is a biotech psychedelic medicine company focused on the clinical development of LSD, Ibogaine, MDMA, DMT, and psilocybin for anxiety, depression, addiction, ADHD, and more.
  • Diverse and robust IP and drug development pipeline focusing on many underserved and large markets.
  • Recently launched a new division focused on developing digital therapeutics for psychedelics.
  • Filed to up-list to the NASDAQ following the successful IPO of another psychedelic company, Compass Pathways.
  • Strong leadership team, partnerships with fantastic institutions, and backed by Kevin O'Leary (Shark Tank) and Bruce Linton (former CEO of Canopy Growth).

For further details see:

MindMed: Severely Undervalued With Massive Upside Yet To Come
Stock Information
Company Name: Mind Medicine
Stock Symbol: MMEDF
Market: OTC
Website: mindmed.co
Menu
MMEDF MMEDF Quote MMEDF Short MMEDF News MMEDF Articles MMEDF Message Board
Get MMEDF Alerts

News, Short Squeeze, Breakout and More Instantly...